JP2023515404A5 - - Google Patents

Info

Publication number
JP2023515404A5
JP2023515404A5 JP2022549132A JP2022549132A JP2023515404A5 JP 2023515404 A5 JP2023515404 A5 JP 2023515404A5 JP 2022549132 A JP2022549132 A JP 2022549132A JP 2022549132 A JP2022549132 A JP 2022549132A JP 2023515404 A5 JP2023515404 A5 JP 2023515404A5
Authority
JP
Japan
Prior art keywords
group
ring
substituted
compound according
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022549132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515404A (ja
JP7836762B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/076260 external-priority patent/WO2021160127A1/en
Publication of JP2023515404A publication Critical patent/JP2023515404A/ja
Publication of JP2023515404A5 publication Critical patent/JP2023515404A5/ja
Priority to JP2025281655A priority Critical patent/JP2026076168A/ja
Application granted granted Critical
Publication of JP7836762B2 publication Critical patent/JP7836762B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022549132A 2020-02-13 2021-02-09 ヘテロ環glp-1アゴニスト Active JP7836762B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025281655A JP2026076168A (ja) 2020-02-13 2025-12-25 ヘテロ環glp-1アゴニスト

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2020075105 2020-02-13
CNPCT/CN2020/075105 2020-02-13
CN2020075103 2020-02-13
CNPCT/CN2020/075103 2020-02-13
PCT/CN2021/076260 WO2021160127A1 (en) 2020-02-13 2021-02-09 Heterocyclic glp-1 agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025281655A Division JP2026076168A (ja) 2020-02-13 2025-12-25 ヘテロ環glp-1アゴニスト

Publications (3)

Publication Number Publication Date
JP2023515404A JP2023515404A (ja) 2023-04-13
JP2023515404A5 true JP2023515404A5 (cg-RX-API-DMAC10.html) 2024-02-20
JP7836762B2 JP7836762B2 (ja) 2026-03-27

Family

ID=77291666

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022549132A Active JP7836762B2 (ja) 2020-02-13 2021-02-09 ヘテロ環glp-1アゴニスト
JP2025281655A Pending JP2026076168A (ja) 2020-02-13 2025-12-25 ヘテロ環glp-1アゴニスト

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025281655A Pending JP2026076168A (ja) 2020-02-13 2025-12-25 ヘテロ環glp-1アゴニスト

Country Status (5)

Country Link
US (1) US20230165846A1 (cg-RX-API-DMAC10.html)
EP (1) EP4103563A4 (cg-RX-API-DMAC10.html)
JP (2) JP7836762B2 (cg-RX-API-DMAC10.html)
CN (1) CN115697999A (cg-RX-API-DMAC10.html)
WO (1) WO2021160127A1 (cg-RX-API-DMAC10.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202191432A1 (ru) 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
TWI751585B (zh) 2019-06-28 2022-01-01 美商美國禮來大藥廠 類升糖素肽1受體促效劑
CR20220178A (es) 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r
EP4069686B1 (en) * 2019-12-02 2025-01-22 Hyundai Pharm Co., Ltd. Glp-1 receptor agonist
SI4097097T1 (sl) 2020-01-29 2025-04-30 Gilead Sciences, Inc. Spojine, ki modulirajo glp-1r
PT4097099T (pt) 2020-02-07 2024-07-19 Gasherbrum Bio Inc Agonistas heterocíclicos de glp-1
MX2022011349A (es) * 2020-03-18 2022-11-10 Lg Chemical Ltd Agonista del receptor de glp-1, composición farmacéutica que comprende el mismo, y método para preparar el mismo.
TW202144340A (zh) * 2020-04-03 2021-12-01 大陸商江蘇恆瑞醫藥股份有限公司 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用
WO2021219019A1 (en) 2020-04-29 2021-11-04 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
PE20231181A1 (es) 2020-08-06 2023-08-11 Gasherbrum Bio Inc Agonistas del glp-1 heterociclicos
JP2023538949A (ja) 2020-08-28 2023-09-12 ガシャーブラム・バイオ・インコーポレイテッド ヘテロ環glp-1アゴニスト
WO2022052958A1 (en) 2020-09-10 2022-03-17 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
EP4247804A1 (en) 2020-11-20 2023-09-27 Gilead Sciences, Inc. Polyheterocyclic glp-1 r modulating compounds
WO2022111624A1 (zh) * 2020-11-27 2022-06-02 深圳信立泰药业股份有限公司 一种苯并咪唑类衍生物及其制备方法和医药用途
EP4304711A1 (en) 2021-03-11 2024-01-17 Gilead Sciences, Inc. Glp-1r modulating compounds
US12180197B2 (en) 2021-03-11 2024-12-31 Gilead Sciences, Inc. GLP-1R modulating compounds
EP4317145A4 (en) 2021-03-24 2025-03-12 Shionogi & Co., Ltd Pharmaceutical composition containing glp-1 receptor agonist having fused ring
US20240300928A1 (en) * 2021-04-08 2024-09-12 Lg Chem, Ltd. Glp-1 receptor agonist, pharmaceutical composition comprising same, and method for preparing same
LT4271672T (lt) 2021-04-21 2026-03-10 Gilead Sciences, Inc. Karboksibenzimidazolo junginiai, moduliuojantys glp-1r
TWI843104B (zh) 2021-05-20 2024-05-21 美商美國禮來大藥廠 類升糖素肽1受體促效劑
CN117098758A (zh) 2021-06-24 2023-11-21 杭州中美华东制药有限公司 Glp-1受体激动剂及其组合物和用途
CN113480534B (zh) * 2021-07-23 2022-05-13 广州必贝特医药股份有限公司 苯并咪唑或氮杂苯并咪唑-6-羧酸类化合物及其应用
KR20240053617A (ko) 2021-08-30 2024-04-24 민드랭크 에이아이 리미티드 Glp1r 작용제로서의 신규 아릴 에테르 치환 헤테로시클릭 화합물
KR20240056719A (ko) 2021-09-08 2024-04-30 시오노기 앤드 컴파니, 리미티드 항비만 작용이 관여하는 질환의 예방 및 치료용 의약
SI4408840T1 (sl) 2021-09-27 2025-12-31 Terns Pharmaceuticals, Inc. Benzimidazolne karboksilne kisline kot agonisti GLP-1R
WO2023057427A1 (en) 2021-10-05 2023-04-13 Astrazeneca Ab Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators
US20250236627A1 (en) 2021-10-05 2025-07-24 Astrazeneca Ab Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
WO2023057429A1 (en) 2021-10-05 2023-04-13 Astrazeneca Ab Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
US12024507B2 (en) 2021-10-25 2024-07-02 Terns Pharmaceuticals, Inc. Compounds as GLP-1R agonists
US20250042882A1 (en) 2021-12-16 2025-02-06 Astrazeneca Ab Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
US20250066338A1 (en) 2021-12-16 2025-02-27 Astrazeneca Ab Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
AU2023224854A1 (en) 2022-02-23 2024-10-03 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
CN116574092B (zh) * 2022-05-20 2024-08-20 成都地奥九泓制药厂 苯并咪唑或氮杂苯并咪唑类化合物、其制备方法及其应用
CN119923395A (zh) * 2022-07-27 2025-05-02 卡莫特医疗有限公司 N-杂环gpcr受体激动剂、包含其的药物组合物和其使用方法
CN119907794A (zh) 2022-09-22 2025-04-29 盐野义制药株式会社 具有glp-1受体激动剂作用的稠环化合物
WO2024102625A1 (en) 2022-11-11 2024-05-16 Eli Lilly And Company Glucagon-like peptide 1 receptor agonists
CR20250178A (es) 2022-11-16 2025-06-06 Lilly Co Eli Agonistas del receptor del péptido-1 similar al glucagón
JP2026501161A (ja) * 2022-12-13 2026-01-14 杭州中美華東製薬有限公司 Glp-1受容体作動薬の新規結晶形、その製造方法、その医薬組成物およびその使用
KR20250168210A (ko) 2023-02-16 2025-12-02 가셔브룸 바이오, 인크. 헤테로시클릭 glp-1 효능제
PE20252787A1 (es) 2023-04-07 2025-12-22 Terns Pharmaceuticals Inc Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica
EP4777197A2 (en) 2023-09-14 2026-07-22 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
AU2024380885A1 (en) * 2023-11-13 2026-05-14 Aspen Neuroscience, Inc. Methods of predicting characteristics of differentiated neuronal cells
WO2025109387A1 (en) 2023-11-24 2025-05-30 Ascletis Pharma (China) Co., Limited Glp-1r agonist and therapeutic method thereof
WO2025158275A1 (en) 2024-01-24 2025-07-31 Pfizer Inc. Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds
TW202600132A (zh) 2024-03-08 2026-01-01 美商安尼波那生物公司 用於治療肥胖症及提高減重之方法
KR20260038229A (ko) 2024-09-11 2026-03-18 한미약품 주식회사 Glp-1 수용체 작용제 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018109607A1 (en) * 2016-12-16 2018-06-21 Pfizer Inc. Glp-1 receptor agonists and uses thereof
FI3806855T3 (fi) * 2018-06-15 2023-05-04 Pfizer Glp-1 -reseptorin agonisteja ja niiden käyttöjä
EA202191432A1 (ru) * 2018-11-22 2021-10-14 Цилу Регор Терапьютикс Инк. Агонисты glp-1r и их применения
AU2020256647B2 (en) * 2019-04-12 2025-07-31 Qilu Regor Therapeutics Inc. GLP-1R agonists and uses thereof
TWI751585B (zh) 2019-06-28 2022-01-01 美商美國禮來大藥廠 類升糖素肽1受體促效劑
WO2021018023A1 (zh) * 2019-08-01 2021-02-04 济南泰达领创医药技术有限公司 小分子glp-1受体调节剂
CR20220178A (es) * 2019-10-25 2022-06-15 Gilead Sciences Inc Compuestos moduladores de glp-1r
EP4069686B1 (en) * 2019-12-02 2025-01-22 Hyundai Pharm Co., Ltd. Glp-1 receptor agonist

Similar Documents

Publication Publication Date Title
JP2023524493A5 (cg-RX-API-DMAC10.html)
JP2023513272A5 (cg-RX-API-DMAC10.html)
JP2023537501A5 (cg-RX-API-DMAC10.html)
JP2023538949A5 (cg-RX-API-DMAC10.html)
JP2023546055A5 (cg-RX-API-DMAC10.html)
JP2023540609A5 (cg-RX-API-DMAC10.html)
JP2023540558A5 (cg-RX-API-DMAC10.html)
JP2023546054A5 (cg-RX-API-DMAC10.html)
JP2025506473A5 (cg-RX-API-DMAC10.html)
JP2025506474A5 (cg-RX-API-DMAC10.html)
JP2010248215A (ja) 筋弛緩促進剤及び筋弛緩不全等の筋組織に係る疾病の治療薬
JP7793614B2 (ja) チアジアゾロン誘導体と、それらの糖尿病および関連疾患の治療のためのampkアゴニストとしての使用
JP2025513071A5 (cg-RX-API-DMAC10.html)
JPWO2011002001A1 (ja) ピラゾール誘導体とビグアナイド薬との組み合わせ医薬
US20230321044A1 (en) Treatment or prevention method for chronic heart failure
US12324799B2 (en) Methods and uses of colchicine derivatives
KR20010108089A (ko) 신규한 2-(n-시아노이미노)티아졸리딘-4-온 유도체
JP5252585B2 (ja) 代謝障害の治療のための化合物
CN105658234A (zh) 拟胰岛淀粉样多肽化合物与聚乙二醇的非-凝聚生物缀合物
CN1162152C (zh) 糖尿病治疗剂
JP2023517613A (ja) 非アルコール性脂肪性肝炎の予防または治療用の薬学的組成物
TW202135812A (zh) 使用整聯蛋白抑制劑組合治療肝臟疾病
JPWO2004039806A1 (ja) 複素環化合物
TWI833718B (zh) 過氧化體增殖物活化受體之活化劑
JPWO2011002011A1 (ja) Sglt1阻害薬とdpp−iv阻害薬を組み合わせてなる医薬